Long-term survival was investigated in 202 patients that underwent isolated aortic valve replacement with 19 mm valves . There were 171 women whit a mean age of 69 ± 9 and 31 men with a mean age of 64 ± 13 . Patients had a mean body surface area of 1,61 ± 0,13 m 2 . Patient-prosthesis mismatch was moderate in 196 and severe in 6 patients . The mean follow-up for all patients was 78 months . There were 79 late deaths. The actuarial survival rates for all patients were 95% ± 1% at 1 year , 75% ± 2% at 5 years 56 ± 2 % at 10 years , 41 % ± 2% at 15 years , 34% ± 3% at 20 years and 34 ± 2% at 25 years . Patients over 70 years old had a lower survival rate ( p = 0,0001 ) . There were significant differences between ejection fraction > 55% and ejection fraction < 55% ( p = 0,0305 ) . Aortic valve replacement with 19 mm valves appeared to provide satisfactory mid-term survival . Age and low ejection fraction were risk factors for shorter survival .
Introduction
Aortic valve replacement ( AVR ) in the small aortic root may be associated with residual obstruction in left ventricular outflow . When AVR is performed , it is considered suboptimal to put a small valve into a patient with a large body surface area. In a previous study ( 1 ) we found that patients that received 19 or 21 mm valves to alleviate aortic stenosis experienced significantly less postoperative regression of left ventricular hypertrophy than patients that received larger valves . Prosthesis patient mismatch ( PPM ) was defined as severe when the effective orifice area index ( EOAI ) was < 0,65 cm 2 / m 2 , moderate when EOAI was between 0,65 and 0,85 cm 2 / m 2 and absent when EOAI was > 0,85 cm 2 / m 2 ( 2 ) . The degree to which PPM affects survival remains unclear and some multicenter studies have demonstrated no impact of PPM on long term survival (3) (4) . The purpose of this study was to evaluate the longterm survival in patients that received 19 mm valves over the last 25 years .
Patients and methods
From October 1978 to July 2008 , 1560 patients underwent isolated AVR by our surgical team . Of this group , long-term survival was investigated in 202 patients that survived isolated AVR with size 19 mm valves . Survival data were obtained for all 202 patients with a 3 month closing interval ending October 2008 . Data were obtained from outpatient visits , telephone calls or the Galicia health service medical records database . Patients that had concomitant cardiac surgery were excluded from this study. No patients had undergone an aortic enlargement procedure . An ejection fraction ( EF ) > 55% was defined as normal . With regard to the long-term survival , seven variables ( age , EF , NYHA , hypertension , diabetes , sex and type of prosthesis ) were investigated by the KaplanMeier method . The predicted functionally effective orifice area was based on the manufacturer´s in vitro data and indexed to patient body surface area , as previously described and validated ( 5 ) .
Operative Technique AVR was performed under cardiopulmonary bypass , myocardial protection was achieved by blood cardioplegia and moderate hypothermia ( 30º -32º C ) . The prosthetic valve was implanted with interrupted pledget reinforced sutures . The types of prostheses included Mitroflow in 116 , Carbomedics in 43 , Ionescu -Shiley in 16 , Labcor -Santiago in 14 and Bicarbon in 13 patients .
Statistical analyses
The cumulative mortality rate was calculated by the Kaplan-Meier method. The hazard ratio ( HR ) and 95% confidence intervals ( 95%CI ) were estimated with a Cox regression analysis . We also used the multiple Cox regression analysis to examine the association between the all-time risk of death and the effects of age adjusted by baseline characteristics ( sex , diabetes , hypertension , ejection fraction ) . For age , given the nonlinear nature of the association , the model was constructed with penalised smoothing splines ( 6 ) . All statistical analyses were carried out in R with the packages Survival (for fitting parametric Cox models), and Splines (for fitting nonparametric Cox models). These packages are freely available at http://cran.r-project.org.
Results
The study included 171 women ( 84,6% ) with a mean age of 69 ± 9 ,range 29 to 87 and 31 men ( 15,3 % ) with a mean age of 64 ± 13, range 16 to 81 . The mean body surface area was 1,61 ± 0,13 m 2 . PPM was moderate in 196 ( 97 % ) and severe in 6 ( 3 % ) patients . Preoperative NYHA class 3-4 was present in 182 ( 90% ) patients . Table  1 shows the pre-operative characteristics of the patients . Early mortality was excluded . The mean follow-up for all patients was 78 ± 74 months postoperatively ( maximum 28 years ). Table 2 shows the number of patients exposed to risk and the cumulative survival at the end of the follow-up . There were 79 late deaths . Figure 1 shows the actuarial survival estimates for all patients . The median survival time was 157,88 months . Patient survival at 20 years was only slightly lower than that of the general population of Galicia ( Spain ) matched for age and gender . (http://www.ine.es/jaxi/tabla.do) accessed 3-27-2009. Table 3 shows the Cox adjusted hazard ratios for all-cause death during the follow-up. In figure 2 , we show the influence of age on long-term survival in patients with size 19 mm valves . Patients over 70 years old had lower survival rates ( p = 0,0001 ) . There were significant differences in survival rates between patients with EF > 55% and patients with EF < 55% ( p = 0,002 ) and between patients with and without diabetes ( p = 0,024 ) .There were no significant differences between survival rates of women and men ( p = 0,30 ) , patients with and without hypertension ( p = 0,53 ) or patients with bioprostheses and those with mechanical prostheses (p = 0,40) . The Cox regression analysis identified age > 70 years ( p =0,0001;RR ; 95% CI 1.018 -1,082 ) and impaired left ventricular function ( EF < 55 % ) ( p = 0,030 ; RR ; 95% CI 0,946 -0,987 ) as the only independent predictors for reduced survival after hospital discharge . Postoperative NYHA class I was present in 78% of patients , class II in 20 % of patients and class III in 2% of patients . 
Discussion
Aortic valve replacement is the procedure of choice for symptomatic patients with severe aortic stenosis . Other Class I indications for AVR in patients with severe aortic stenosis include patients undergoing coronary artery bypass graft surgery , surgery on the aorta or surgery on other heart valves . The appropriate choice of a valve substitute is one of the most important decisions in surgery for aortic valve replacement . A good choice is associated with a reduction in left ventricular mass and in improvement of left ventricular diastolic filling, but all valves substitutes leave some residual stenosis ( 7 ) . Previously we suggested the possibility that small valves were too inefficient to allow adequate regression of left ventricular hypertrophy and we predicted that small valves would eventually prove detrimental to the patient ( 8 ) , we concluded that " this possibility should be investigated more fully " . Rahimtoola ( 9 ) defined PPM as the condition in which the in vivo prosthetic valve effective orifice area is less than that of a native valve . However there are many variations on this definition ( 5 ) . In this study most patients had moderate PPM . Eichinger ( 10 ) found that with a 19 mm bioprosthesis , PPM occurred in 100 % of the cases . Walther and colleagues ( 11 ) reported that a moderate PPM significantly impacted long-term survival . On the other hand , in a multicenter study , Blackstone ( 4 ) reported that PPM with AVR had no impact on long-term survival ; similar results were reported by Rao and colleagues ( 12 ) . Similar to the Blackstone study ( 4 ) , the present report focused on survival alone , without taking into account left ventricular mass regression . We demonstrated that AVR with size 19 mm valves may provide satisfactory mid-term results . Among patients that survived the perioperative period in our group , actuarial survival rates were 95% ± 1% at 1 year , 75% ± 2% at 5 years , 56 ± 2 % at 10 years , 41 % ± 2% at 15 years , 34% ± 3% at 20 years and 34 ± 2% at 25 years . Others studies have reported similar survival rates ( 2,13 ) , but only Carrier ( 13 ) reported results with 19 mm valves . Rao and co-authors ( 12 ) noted improved survival in patients that received a 23 mm or larger valve compared with those that received a 19 mm valve . As expected , we found a clear influence of age on the long-term survival . Howell et al. ( 3 ) reported that advanced age at the time of surgery was the only predictor of adverse long-term survival . In the present study , the 10-year survival reached 42% ± 4% in patients over 70 years old and 60% ± 5,3% in younger patients . Guo-Wei and colleagues ( 14 ) reported a similar influence of age , although they observed better survival rates . Reul and associates ( 15 ) monitored 805 patients that underwent AVR and reported reduced survival with PPM in patients with low EF , but not in those with normal EF . In our study low , low EF was a significant risk factor for the long-term survival .
Conclusion : PPM may occur in all patients undergoing AVR with 19 mm valves , but the influence of PPM on mid-term survival may be less than previously hypothesized . Advanced age and low EF are risk factors for reduced mid-term survival . Our results suggest that PPM should be avoided in patients with low preoperative EF .
Limitations of the study This is not a randomized study and it is retrospective . This study does not examine all outcomes , but only long-survival . There is not a control group . The number of patients with long-term follow-up may have been too small for conclusive results .
